FDA Inspection 1084973 — Cipla, Ltd.

Cipla, Ltd. — FEI 3002806702

The FDA completed an inspection of Cipla, Ltd. on March 20, 2019 in Kurkumbh Village, Dist. Pune. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 20, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Kurkumbh Village, Dist. Pune (India)